_id

690f3b60ccc777a4e85d19ba

Ticker

CASI

Name

CASI Pharmaceuticals Inc

Exchange

NASDAQ

Address

1701-1702, China Central Office Tower 1, Beijing, China, 100025

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.casipharmaceuticals.com

Description

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company's hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investigative product; BI-1206, an novel anti-Fc"RIIB antibody for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; CID-103, a human IgG1 anti-CD38 monoclonal antibody; and Thiotepa, a chemotherapeutic agent, which has various indications, including use as a conditioning treatment for use prior to certain allogeneic haemopoietic stem cell transplants. It has licensing agreements with Juventas Cell Therapy Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China.

Last Close

0.935

Volume

36160

Current Price

0.863

Change

-7.700534759358295

Last Updated

2025-11-29T11:09:33.106Z

Image

-

Ipo Date

1996-06-11T00:00:00.000Z

Market Cap

20959238

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.402

Sentiment Sources

1

Rating

4

Target Price

4

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

3075000

Cost Of Revenue

2369000

Gross Profit

706000

Operating Expenses

11383000

Operating Income

-10677000

Interest Expense

195000

Pretax Income

-10883000

Net Income

-10883000

Eps

-0.6780972651800824

Dividends Per Share

-

Shares Outstanding

20548273

Income Tax Expense

-

EBITDA

-10105250

Operating Margin

-347.2195121951219

Total Other Income Expense Net

-206000

Cash

4685000

Short Term Investments

0

Receivables

2609000

Inventories

2611000

Total Current Assets

11915000

Property Plant Equipment

9947000

Total Assets

24462000

Payables

560000

Short Term Debt

18855000

Long Term Debt

-

Total Liabilities

53054000

Equity

-28592000

Depreciation

582750

Change In Working Capital

-

Cash From Operations

-

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-

Net Change In Cash

-2055000

PE

-

PB

-0.4844209275321768

ROE

38.06309457190822

ROA

-44.4894121494563

FCF

-

Fcf Percent

-

Piotroski FScore

0

Health Score

38

Deep Value Investing Score

1

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2.5

Growth Investing Score

2.5

Momentum Investing Score

3.5

Net Net Investing Score

0.5

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3075000

Quarters > 0 > income Statement > cost Of Revenue

2369000

Quarters > 0 > income Statement > gross Profit

706000

Quarters > 0 > income Statement > operating Expenses

11383000

Quarters > 0 > income Statement > operating Income

-10677000

Quarters > 0 > income Statement > interest Expense

195000

Quarters > 0 > income Statement > pretax Income

-10883000

Quarters > 0 > income Statement > net Income

-10883000

Quarters > 0 > income Statement > eps

-0.6780972651800824

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

16049320

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-10105250

Quarters > 0 > income Statement > operating Margin

-347.2195121951219

Quarters > 0 > income Statement > total Other Income Expense Net

-206000

Quarters > 0 > balance Sheet > cash

4685000

Quarters > 0 > balance Sheet > short Term Investments

0

Quarters > 0 > balance Sheet > receivables

2609000

Quarters > 0 > balance Sheet > inventories

2611000

Quarters > 0 > balance Sheet > total Current Assets

11915000

Quarters > 0 > balance Sheet > property Plant Equipment

9947000

Quarters > 0 > balance Sheet > total Assets

24462000

Quarters > 0 > balance Sheet > payables

560000

Quarters > 0 > balance Sheet > short Term Debt

18855000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

53054000

Quarters > 0 > balance Sheet > equity

-28592000

Quarters > 0 > cash Flow > net Income

-10883000

Quarters > 0 > cash Flow > depreciation

582750

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-

Quarters > 0 > cash Flow > net Change In Cash

-2055000

Quarters > 0 > ratios > PE

-0.6780972651800824

Quarters > 0 > ratios > PB

-0.4844209275321768

Quarters > 0 > ratios > ROE

38.06309457190822

Quarters > 0 > ratios > ROA

-44.4894121494563

Quarters > 0 > ratios > FCF

-

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

4175000

Quarters > 1 > income Statement > cost Of Revenue

2117000

Quarters > 1 > income Statement > gross Profit

2058000

Quarters > 1 > income Statement > operating Expenses

13183000

Quarters > 1 > income Statement > operating Income

-11125000

Quarters > 1 > income Statement > interest Expense

244000

Quarters > 1 > income Statement > pretax Income

-11201000

Quarters > 1 > income Statement > net Income

-13375000

Quarters > 1 > income Statement > eps

-0.8625750577344864

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

15505897

Quarters > 1 > income Statement > income Tax Expense

2174000

Quarters > 1 > income Statement > EBITDA

-10957000

Quarters > 1 > income Statement > operating Margin

-266.4670658682635

Quarters > 1 > income Statement > total Other Income Expense Net

-76000

Quarters > 1 > balance Sheet > cash

6740000

Quarters > 1 > balance Sheet > short Term Investments

22000

Quarters > 1 > balance Sheet > receivables

5363000

Quarters > 1 > balance Sheet > inventories

3397000

Quarters > 1 > balance Sheet > total Current Assets

18162000

Quarters > 1 > balance Sheet > property Plant Equipment

10450000

Quarters > 1 > balance Sheet > total Assets

31202000

Quarters > 1 > balance Sheet > payables

805000

Quarters > 1 > balance Sheet > short Term Debt

18734000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

51512000

Quarters > 1 > balance Sheet > equity

-20310000

Quarters > 1 > cash Flow > net Income

-13375000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-

Quarters > 1 > cash Flow > net Change In Cash

-4157000

Quarters > 1 > ratios > PE

-0.8625750577344864

Quarters > 1 > ratios > PB

-0.6588670167897588

Quarters > 1 > ratios > ROE

65.85425898572132

Quarters > 1 > ratios > ROA

-42.86584193320941

Quarters > 1 > ratios > FCF

-

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

6240000

Quarters > 2 > income Statement > cost Of Revenue

2621000

Quarters > 2 > income Statement > gross Profit

3619000

Quarters > 2 > income Statement > operating Expenses

13998000

Quarters > 2 > income Statement > operating Income

-10379000

Quarters > 2 > income Statement > interest Expense

197000

Quarters > 2 > income Statement > pretax Income

-10750000

Quarters > 2 > income Statement > net Income

-10750000

Quarters > 2 > income Statement > eps

-0.6938767474801785

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

15492665

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-10553000

Quarters > 2 > income Statement > operating Margin

-166.3301282051282

Quarters > 2 > income Statement > total Other Income Expense Net

-371000

Quarters > 2 > balance Sheet > cash

10897000

Quarters > 2 > balance Sheet > short Term Investments

1802000

Quarters > 2 > balance Sheet > receivables

7600000

Quarters > 2 > balance Sheet > inventories

4153000

Quarters > 2 > balance Sheet > total Current Assets

27164000

Quarters > 2 > balance Sheet > property Plant Equipment

10920000

Quarters > 2 > balance Sheet > total Assets

40821000

Quarters > 2 > balance Sheet > payables

1195000

Quarters > 2 > balance Sheet > short Term Debt

18492000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

48891000

Quarters > 2 > balance Sheet > equity

-8070000

Quarters > 2 > cash Flow > net Income

-10750000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

-

Quarters > 2 > cash Flow > net Change In Cash

-2571000

Quarters > 2 > ratios > PE

-0.6938767474801785

Quarters > 2 > ratios > PB

-1.656774460346964

Quarters > 2 > ratios > ROE

133.2094175960347

Quarters > 2 > ratios > ROA

-26.334484701501676

Quarters > 2 > ratios > FCF

-

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

13356000

Quarters > 3 > income Statement > cost Of Revenue

10128000

Quarters > 3 > income Statement > gross Profit

3228000

Quarters > 3 > income Statement > operating Expenses

16142000

Quarters > 3 > income Statement > operating Income

-12914000

Quarters > 3 > income Statement > interest Expense

694000

Quarters > 3 > income Statement > pretax Income

-14370000

Quarters > 3 > income Statement > net Income

-14370000

Quarters > 3 > income Statement > eps

-0.927540737079251

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

15492581

Quarters > 3 > income Statement > income Tax Expense

73000

Quarters > 3 > income Statement > EBITDA

-9757250

Quarters > 3 > income Statement > operating Margin

-96.69062593590895

Quarters > 3 > income Statement > total Other Income Expense Net

-1456000

Quarters > 3 > balance Sheet > cash

13468000

Quarters > 3 > balance Sheet > short Term Investments

2623000

Quarters > 3 > balance Sheet > receivables

15345000

Quarters > 3 > balance Sheet > inventories

5252000

Quarters > 3 > balance Sheet > total Current Assets

39576000

Quarters > 3 > balance Sheet > property Plant Equipment

11360000

Quarters > 3 > balance Sheet > total Assets

53674000

Quarters > 3 > balance Sheet > payables

2723000

Quarters > 3 > balance Sheet > short Term Debt

19606000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

51823000

Quarters > 3 > balance Sheet > equity

1851000

Quarters > 3 > cash Flow > net Income

-14370000

Quarters > 3 > cash Flow > depreciation

582750

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-

Quarters > 3 > cash Flow > net Change In Cash

-3068999

Quarters > 3 > ratios > PE

-0.927540737079251

Quarters > 3 > ratios > PB

7.22317525823879

Quarters > 3 > ratios > ROE

-776.3371150729336

Quarters > 3 > ratios > ROA

-26.7727391288147

Quarters > 3 > ratios > FCF

-

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

16

Valuation > metrics > PE

-0.6780972651800824

Valuation > metrics > PB

-0.4844209275321768

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

38.06309457190822

Profitability > metrics > ROA

-91.33864876206462

Profitability > metrics > Net Margin

-3.5391869918699186

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-54.753846153846155

Risk > final Score

-189

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.6137007468452228

Liquidity > metrics > Quick Ratio

0.47921710018027297

Liquidity > final Score

34

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

20

Prev Profitabilities > 0

40

Prev Profitabilities > 1

40

Prev Profitabilities > 2

0

Prev Risks > 0

-152

Prev Risks > 1

-181

Prev Risks > 2

-68

Prev Liquidities > 0

48

Prev Liquidities > 1

84

Prev Liquidities > 2

94

Updated At

2025-12-14T00:18:56.316Z